Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Pharmacology

• Publication date

  2015-09-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2015.05.013PMID 25981303PMCID PMC4584177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and function of serotonin G protein-coupled receptors.

  2015cited by this paper
• Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli

  2014cited by this paper
• Muscarinic acetylcholine receptors: novel opportunities for drug development

  2014cited by this paper
• Structural and functional insights into the juxtamembranous amino‐terminal tail and extracellular loop regions of class B GPCRs

  2014cited by this paper
• Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

  2014influential reference
• Unifying family A GPCR theories of activation.

  2014cited by this paper
• Structure-based drug design for G protein-coupled receptors.

  2014cited by this paper
• Structure of Class B GPCRs: new horizons for drug discovery

  2014cited by this paper
• Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

  2014cited by this paper
• Visualization of arrestin recruitment by a G Protein-Coupled Receptor

  2014cited by this paper
• Molecular control of δ-opioid receptor signalling

  2014cited by this paper
• Selective CGRP and adrenomedullin peptide binding by tethered RAMP‐calcitonin receptor‐like receptor extracellular domain fusion proteins

  2013cited by this paper
• Structure-function of the G protein-coupled receptor superfamily.

  2013cited by this paper
• Activation and allosteric modulation of a muscarinic acetylcholine receptor

  2013cited by this paper
• Structure of the human glucagon class B G-protein-coupled receptor

  2013cited by this paper
• Molecular signatures of G-protein-coupled receptors

  2013cited by this paper
• Structure of the human smoothened receptor bound to an antitumour agent

  2013influential reference
• Structural mechanism of ligand activation in human GABAB receptor

  2013cited by this paper
• Structural Basis for Molecular Recognition at Serotonin Receptors

  2013influential reference
• Direct molecular evolution of detergent-stable G protein-coupled receptors using polymer encapsulated cells.

  2013cited by this paper
• Structure of class B GPCR corticotropin-releasing factor receptor 1

  2013influential reference
• Structural Features for Functional Selectivity at Serotonin Receptors

  2013influential reference
• The importance of interactions with helix 5 in determining the efficacy of β-adrenoceptor ligands.

  2013cited by this paper
• Structure of the human kappa opioid receptor in complex with JDTic

  2012cited by this paper
• Structure of the agonist-bound neurotensin receptor

  2012cited by this paper
• Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor

  2012influential reference
• A crystal clear solution for determining G-protein-coupled receptor structures.

  2012cited by this paper
• Crystal Structure of a Lipid G Protein–Coupled Receptor

  2012cited by this paper
• Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR

  2012cited by this paper
• Restructuring G-protein- coupled receptor activation.

  2012cited by this paper
• Diversity and modularity of G protein-coupled receptor structures.

  2012cited by this paper
• Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic

  2012cited by this paper
• Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

  2012influential reference
• Structure of the δ-opioid receptor bound to naltrindole

  2012influential reference
• Pathway and mechanism of drug binding to G-protein-coupled receptors

  2011cited by this paper
• Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues

  2011cited by this paper
• Lipidic cubic phase technologies for membrane protein structural studies.

  2011cited by this paper
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist

  2011influential reference
• Structure of a nanobody-stabilized active state of the β2 adrenoceptor

  2010cited by this paper
• NMR Structure of the First Extracellular Domain of Corticotropin-releasing Factor Receptor 1 (ECD1-CRF-R1) Complexed with a High Affinity Agonist*

  2010cited by this paper
• Structural Basis for Hormone Recognition by the Human CRFR2α G Protein-coupled Receptor*

  2010influential reference
• Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

  2010cited by this paper
• Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor*

  2009cited by this paper
• Structural Basis for Parathyroid Hormone-related Protein Binding to the Parathyroid Hormone Receptor and Design of Conformation-selective Peptides*

  2009cited by this paper
• Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain*

  2008cited by this paper
• Structural diversity of G protein-coupled receptors and significance for drug discovery

  2008cited by this paper
• Molecular recognition of parathyroid hormone by its G protein-coupled receptor

  2008cited by this paper
• Structural diversity of G protein-coupled receptors and significance for drug discovery

  2008cited by this paper
• 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.

  2008cited by this paper
• Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1*

  2008cited by this paper
• Faculty Opinions recommendation of GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.

  2007cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007influential reference
• GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function

  2007cited by this paper
• Structures of the extracellular regions of the group II/III metabotropic glutamate receptors

  2007cited by this paper
• A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor

  2007cited by this paper
• Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor

  2007cited by this paper
• Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand

  2007cited by this paper
• Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.

  2006cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Protein crystallography microdiffraction.

  2005cited by this paper
• Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor

  2005cited by this paper
• Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.

  2005cited by this paper
• The activation mechanism of class-C G-protein coupled receptors

  2004cited by this paper
• The Activation Mechanism of Class-III G-Protein Coupled Receptors

  2004cited by this paper
• CRF and CRF receptors: role in stress responsivity and other behaviors.

  2004cited by this paper
• Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.

  2004cited by this paper
• Dmt and opioid peptides: A potent alliance

  2003cited by this paper
• The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

  2003influential reference
• Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+

  2002cited by this paper
• Molecular biology of serotonin receptors structure and function at the molecular level.

  2002cited by this paper
• The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.

  2001cited by this paper
• Ablation of Serotonin 5-HT2B Receptors in Mice Leads to Abnormal Cardiac Structure and Function

  2001cited by this paper
• Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.

  2001cited by this paper
• Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.

  2000cited by this paper
• Ergotamine in the acute treatment of migraine: a review and European consensus.

  2000cited by this paper
• Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop.

  2000cited by this paper
• Complementarity of delta opioid ligand pharmacophore and receptor models.

  1999cited by this paper
• Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT1B/1D receptors and α2‐adrenoceptors

  1999cited by this paper
• Complementarity of δ opioid ligand pharmacophore and receptor models

  1999cited by this paper
• Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis.

  1998cited by this paper
• Valvular heart disease associated with fenfluramine-phentermine.

  1997cited by this paper
• Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept.

  1997cited by this paper
• Valvular heart disease associated with fenfluramine-phentermine.

  1997cited by this paper
• [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors

  1995cited by this paper
• GCRDb: a G-protein-coupled receptor database.

  1994cited by this paper
• Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists.

  1989cited by this paper
• Peptides as receptor selectivity modulators of opiate pharmacophores.

  1986cited by this paper
• Annual Review of Pharmacology and Toxicology

  1977cited by this paper

• A structural overview of G-protein-coupled receptors in neurological disorders.

  2026cites this paper
• Phylogenetic and Structural Insights into Melatonin Receptors in Plants: Case Study in Capsicum chinense Jacq

  2025cites this paper
• Investigating the Structural Basis of Diacetyl Recognition by the G‑Protein-Coupled Receptor ODR-10 in Caenorhabditis elegans

  2025cites this paper
• Molecular Recognition at the Opioid-modulating Neuropeptide FF Receptor 1.

  2025cites this paper
• Study on the mechanism of floral aroma compounds in sweet oranges inducing the sweetness enhancement of Erythritol by using sensory evaluation, electronic tongue and molecular simulation.

  2025cites this paper
• Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors.

  2024cites this paper
• Dynamic Mechanism for Subtype Selectivity of Endocannabinoids

  2024cites this paper
• Study on the mechanism of glucose-lowering and sweetening of key sweet aroma compounds in sweet orange.

  2024cites this paper
• In silico analysis of crustacean hyperglycemic hormone family G protein-coupled receptor candidates

  2024cites this paper
• The role of G-proteins and G-protein-coupledreceptors in human disease

  2023cites this paper
• Targeting class A GPCRs for hard tissue regeneration.

  2023cites this paper
• Historical perspectives and recent advances in small molecule ligands of selective/biased/multi-targeted μ/δ/κ opioid receptor (2019-2022).

  2023cites this paper
• 3DDPDs: describing protein dynamics for proteochemometric bioactivity prediction. A case for (mutant) G protein-coupled receptors

  2023cites this paper
• Molecular simulations of SSTR2 dynamics and interaction with ligands

  2023cites this paper
• Activation and Speciation Mechanisms in Class A GPCRs

  2022cites this paper
• New Insights into the Structure and Function of Class B1 GPCRs

  2022cites this paper
• Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors

  2022cites this paper
• Biased Activation Mechanism Induced by GPCR Heterodimerization: Observations from μOR/δOR Dimers

  2022cites this paper
• The Structure-property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021.

  2022cites this paper
• Recognition of the ligand-induced spatiotemporal residue pair pattern of β2-adrenergic receptors using 3-D residual networks trained by the time series of protein distance maps

  2022cites this paper
• Photoswitchable allosteric modulators for metabotropic glutamate receptors.

  2022cites this paper
• GPCR-IFP: A Web Server for Analyzing G-Protein Coupled Receptor-Ligand Fingerprint Interaction from Experimental Structures

  2022cites this paper
• Structural Insights into Ligand—Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors

  2021cites this paper
• Drug Receptor Interactions, Metabolism, and Preclinical Drugs for SARS COV 2

  2021cites this paper
• Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands

  2021cites this paper
• Development and Evaluation of a Versatile Receptor-Ligand Binding Assay Using Cell Membrane Preparations Embedded in an Agarose Gel Matrix and Evaluation with the Human Adenosine A1 Receptor

  2020cites this paper
• Structural diversity in ligand recognition by GPCRs

  2020cites this paper
• Spatiotemporal regulation of anti-remodelling signalling pathways in primary human lung fibroblasts

  2020cites this paper
• Exploring the Heteromeric Interface of the 5-HT2A-mGlu2 Receptor Complex

  2020cites this paper
• Structure and selectivity engineering of the M1 muscarinic receptor toxin complex

  2020cites this paper
• Structure-based development of a subtype-selective orexin 1 receptor antagonist

  2020cites this paper
• Molecular characterization of ligand selectivity of the sex peptide receptors of Drosophila melanogaster and Aedes aegypti.

  2020cites this paper
• Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?

  2019cites this paper
• Design and evaluation of fluorescent and non-fluorescent bivalent ligands to explore their mode of action at neuropeptide Y receptors

  2019influential citation
• A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data

  2019cites this paper
• Discovery of a highly selective and potent kappa opioid receptor agonist from N-cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydro- northebaines with reduced central nervous system (CNS) side effects navigated by the message-address concept.

  2019cites this paper
• Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters

  2019cites this paper
• In vitro validation of peptide-T3 conjugates as a treatment option for MCT8-deficiency via a “Trojan Horse”-like mechanism

  2019cites this paper
• New Binding Sites, New Opportunities for GPCR Drug Discovery.

  2019cites this paper
• Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know.

  2018cites this paper
• Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma

  2018cites this paper
• Peptide recognition, signaling and modulation of class B G protein-coupled receptors.

  2018cites this paper
• Mutant Rhodopsins in Autosomal Dominant Retinitis Pigmentosa Display Variable Aggregation Properties

  2018cites this paper
• Novel insights into dishevelled and frizzled function

  2018influential citation
• Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists

  2018cites this paper
• Single-Neuron Comparison of the Olfactory Receptor Response to Deuterated and Nondeuterated Odorants.

  2018cites this paper
• Tracking yeast pheromone receptor Ste2 endocytosis using fluorogen-activating protein tagging

  2018cites this paper
• Current status of G-protein coupled receptors as potential targets against type 2 diabetes mellitus.

  2018cites this paper
• Full rescue of an inactive olfactory receptor mutant by elimination of an allosteric ligand-gating site

  2018cites this paper
• Botulinum Neurotoxin: A Multifunctional Protein for the Development of New Therapeutics

  2017cites this paper
• Potential of GPCR-Targeting Insecticides for Control of Arthropod Vectors

  2017cites this paper
• The Science Behind G Protein-Coupled Receptors (GPCRs) and Their Accurate Visual Representation in Scientific Research

  2017cites this paper
• Complex Pharmacology of Free Fatty Acid Receptors.

  2017cites this paper
• Vitamin B12 Bioconjugates In Pharmaceutical Design

  2017cites this paper
• Photoaffinity Labeling of the Human A2A Adenosine Receptor and Cross-link Position Analysis by Mass Spectrometry.

  2017cites this paper
• Computational insights into the subtype selectivity and “message-address-efficacy” mechanisms of opioid receptors through JDTic binding and unbinding

  2017cites this paper
• Photoaffinity Labeling for Structural Probing Within Protein

  2017cites this paper
• Common evolutionary binding mode of rhodopsin-like GPCRs: Insights from structural bioinformatics

  2017cites this paper
• Allostery and Biased Agonism at Class B G Protein-Coupled Receptors.

  2017cites this paper
• Integration on Ligand and Structure Based Approaches in GPCRs

  2017cites this paper
• Photoaffinity Labeling in Drug Discovery Research

  2017cites this paper
• Modelling of serotonergic receptors and molecular optimization of X-ray crystal structures of serotonin transporter and their interactions with exogenous compounds

  2016influential citation
• Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.

  2016cites this paper
• Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research

  2016cites this paper
• Interaction of G protein coupled receptors and cholesterol.

  2016cites this paper
• Computational insight into conformational states of glucagon-like peptide-1 receptor (GLP-1R) and its binding mode with GLP-1

  2016cites this paper
• Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

  2016cites this paper
• Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

  2016cites this paper
• Direct Modulation of Heterotrimeric G Protein-coupled Signaling by a Receptor Kinase Complex*

  2016cites this paper
• Modeling of glutamatergic and GABAergic drug targets in the CNS and their interactions with environmental toxicants

  2016cites this paper
• Emerging Approaches to GPCR Ligand Screening for Drug Discovery.

  2015cites this paper
• A Simplified Schematic Representation of Cell-based High-Throughput Screening ( HTS ) , Structure-based and Sensor-based Ligand Discovery Approaches

  2015cites this paper